FineTest
SKU:FNab03484
anti- GLO1 antibody
anti- GLO1 antibody
Couldn't load pickup availability
Unleash the potential of glyoxalase 1 (GLO1) and its pivotal roles in glycation research, cellular detoxification, and metabolic studies with our highly specific Anti-GLO1 Antibody. Key features of this research tool include:
-
High Specificity: This antibody is expertly designed to specifically target GLO1, ensuring accuracy and reliability in your research. It recognizes GLO1 with exceptional specificity, enabling precise data interpretation.
-
Metabolic Insights: Explore GLO1's involvement in detoxifying glyoxal and methylglyoxal, its potential implications in diabetes and aging, and its importance in glycation processes.
-
Ideal Size: The 100µg quantity provides enough reagent for multiple experiments while maintaining product freshness and quality.
-
Versatile Applications: This antibody is suitable for various research methodologies, whether you're investigating glyoxalase activity, glycation reactions, or GLO1's interactions with other detoxification enzymes.
Empower your research in the fields of metabolism, glycation, and cellular detoxification as you uncover the multifaceted roles of GLO1.
Product Name
GLO1 antibody
Size
100µg
Form
liquid
Purification
Immunogen affinity purified
Purity
≥95% as determined by SDS-PAGE
Host
Rabbit
Clonality
polyclonal
Isotype
IgG
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
BACKGROUND
Catalyzes the conversion of hemimercaptal, formed from methylglyoxal and glutathione, to S-lactoylglutathione. Involved in the regulation of TNF-induced transcriptional activity of NF-kappa-B. Required for normal osteoclastogenesis.
IMMUNOGEN INFORMATION
Immunogen
glyoxalase I
Observed MW
21-25 kDa
APPLICATION
Tested Application
ELISA, WB
Recommended Dilution
WB: 1:500-1:2000
UNIPROT INFORMATION
UniProt ID
IMAGES

HepG2 cells were subjected to SDS PAGE followed by western blot with FNab03484(GLO1 antibody) at dilution of 1:1000
Share
